VXA-CoV2-3.1

N/A

Report date: 2024/11/06 20:00:41

Base Information

Drug NameVXA-CoV2-3.1
Drug Alias NameVXA-CoV2-3.1
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesDynavax Technologies CorpVaxart Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A